All proposals must be submitted in accordance with the requirements specified in the funding opportunity and in the Proposal & Award Policies & Procedures Guide (PAPPG) and its supplements. All NSF ...
Johnson & Johnson, which was part of the wave of the first cell therapies, is now getting a next-generation contender by paying $785 million to start a partnership on a Sail Biomedicines cell therapy ...
For the very first time, biologists packed nonliving components into a cell-like membrane, piece by piece, and witnessed the bag of molecules start to behave like life. The lab-made synthetic cell ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
The first time I saw living cells emit light, I realized I was watching biology express itself in an entirely different way. Not through molecules, genes, or structures, but through a faint physical ...
Complete the form below to receive the poster. Spatial transcriptomics has transformed our ability to map gene expression within intact tissues, yet most existing approaches require specialized ...
Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...
Cellares reported that the first two patients have been dosed with Cabaletta Bio’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) manufactured on Cellares’ Cell Shuttle™ ...
First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers. A separate Phase 1 trial evaluating HB2198 in patients with ...
A computer platform that runs on human neurons (and recently showed off said neurons’ ability to play DOOM) now wants in on the data center boom. Australia-based Cortical Labs announced today that it ...
M&G Investments has led a $50 million Series C funding round for bit.bio, a Cambridge-based biotechnology company developing human cell programming technology to improve the speed and predictability ...
Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results